Biocept, Inc.
BIOCQ
$0.00
$0.000.00%
06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 6.63M | 6.77M | 12.90M | 18.02M | 22.93M |
Total Receivables | 800.00K | 1.11M | 2.15M | 6.40M | 17.38M |
Inventory | 551.00K | 704.00K | 757.00K | 1.90M | 2.25M |
Prepaid Expenses | 876.00K | 500.00K | 538.00K | 949.00K | 1.23M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 8.86M | 9.09M | 16.34M | 27.26M | 43.78M |
|
|||||
Total Current Assets | 8.86M | 9.09M | 16.34M | 27.26M | 43.78M |
Net Property, Plant & Equipment | 12.86M | 13.52M | 14.14M | 14.08M | 13.87M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 386.00K | 386.00K | 386.00K | 392.00K | 496.00K |
Total Assets | 22.10M | 22.99M | 30.87M | 41.73M | 58.14M |
|
|||||
Total Accounts Payable | 1.47M | 1.53M | 1.52M | 3.04M | 4.83M |
Total Accrued Expenses | 1.53M | 1.30M | 2.25M | 2.18M | 2.74M |
Short-term Debt | 526.00K | -- | 117.00K | 384.00K | 524.00K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.38M | 1.56M | 1.62M | 1.55M | 1.52M |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 4.90M | 4.39M | 5.51M | 7.15M | 9.61M |
|
|||||
Total Current Liabilities | 4.90M | 4.39M | 5.51M | 7.15M | 9.61M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 526.00K | -- | 117.00K | 384.00K | 524.00K |
Capital Leases | 9.69M | 10.02M | 10.38M | 10.33M | 10.42M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 7.23M | 6.15M | 6.13M | 6.11M | 5.65M |
Total Liabilities | 21.81M | 20.57M | 22.01M | 23.58M | 25.69M |
|
|||||
Common Stock & APIC | 309.50M | 308.01M | 307.30M | 306.88M | 306.83M |
Retained Earnings | -309.21M | -305.58M | -298.44M | -288.73M | -274.37M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 290.00K | 2.43M | 8.86M | 18.15M | 32.46M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 290.00K | 2.43M | 8.86M | 18.15M | 32.46M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 290.00K | 2.43M | 8.86M | 18.15M | 32.46M |
|